Alzheimer’s/Dementia

Biogen sees positive results in Alzheimer’s trial, shares

Biogen Inc. shares surged more than 18% Friday after the biotechnology company and Tokyo-based Eisai Co. Ltd. announced positive results from a mid-stage trial of a treatment for Alzheimer’s disease.

Read More >>

Study connects dementia and chronic inflammation

Heightened levels of brain inflammation biomarkers have been linked to the development of dementia, but it remains unclear whether inflammation must be present long-term in order to affect brain health.

 

 

 
Read More >>

Alzheimer’s Association should see healthy amount of proposed $401 million funding increase

The Alzheimer’s Association, its advocacy arm the Alzheimer’s Impact Movement and its nationwide network of advocates are celebrating another proposed funding increase for Alzheimer’s and dementia research at the National Institutes of Health.

Read More >>

New dementia study connects back to Cold War aptitude test

Researchers hope to identify factors that help prevent Alzheimer's disease by comparing the test scores from nearly 60 years ago to health status now.

Read More >>

The WHO’s focus on dementia

The WHO Global Action Plan focuses on the public health's response to dementia, and outlines ways in which governments can address the health and social aspects of the condition.

Read More >>

Bill would ban future residents with dementia, hospice needs from 12 DC facilities

If passed, a local Council bill in Washington, D.C., would ban the 12 assisted living communities in the nation’s capital from accepting residents who have been diagnosed with dementia or need hospice care.

Read More >>

Alzheimer’s bill would authorize $37 million for research, care

Public health leaders and caregivers coalesced Tuesday behind an effort to focus attention and funding on Alzheimer’s disease.

Read More >>

Patients, families consider social and financial impact for Alzheimer’s treatment

Earlier in the year, a report released by the Alzheimer’s Association stated the annual cost of providing care for Americans with Alzheimer’s disease had reached $277 billion.

Read More >>

Virtual Dementia Tour provides a 20-minute dementia experience

The 20-minute experience simulates the effects of aging and dementia, giving the viewer the opportunity to walk in the loved one’s shoes.

Read More >>

Study shows Visual Association Test valuable in the identification of raised dementia risk

Researchers concluded that the VAT “can help to distinguish those at increased risk of developing dementia (requiring counseling, additional examination, or both) from those in whom watchful waiting is justified.”

Read More >>